Investing.com - Biondvax Pharma ADR reported on Thursday fourth quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Biondvax Pharma ADR announced earnings per share of ₪-0.01 on revenue of ₪0.00. Analysts polled by Investing.com anticipated EPS of ₪-0.01 on revenue of ₪0.00.
Biondvax Pharma ADR shares are up 95.73% from the beginning of the year, still down 91.13% from its 52 week high of ₪62.00 set on July 13, 2020. They are outperforming the Nasdaq which is up 3.48% from the start of the year.
Biondvax Pharma ADR shares lost 2.73% in after-hours trade following the report.
Biondvax Pharma ADR follows other major Healthcare sector earnings this month
Biondvax Pharma ADR's report follows an earnings beat by J&J on Tuesday, who reported EPS of ₪1.86 on revenue of ₪22.48B, compared to forecasts EPS of ₪1.83 on revenue of ₪21.69B.
Abbott Labs had beat expectations on Wednesday with fourth quarter EPS of ₪1.45 on revenue of ₪10.7B, compared to forecast for EPS of ₪1.35 on revenue of ₪9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar